DECISION

Fair Work Act 2009
s.185—Enterprise agreement

Aspen Pharma Pty Ltd
(AG2019/510)

ASPEN PHARMA PTY LTD ENGINEERING AGREEMENT 2019

Manufacturing and associated industries
COMMISSIONER WILSON	MELBOURNE, 26 JUNE 2019

Application for approval of the Aspen Pharma Pty Ltd Engineering Agreement 2019.

[1] An application has been made for approval of an enterprise agreement known as the Aspen Pharma Pty Ltd Engineering Agreement 2019 (the Agreement). The application was made pursuant to s.185 of the Fair Work Act 2009 (the Act). It has been made by Aspen Pharma Pty Ltd. The Agreement is a single enterprise agreement.

[2] The Employer has provided written undertakings. A copy of the undertakings is attached in Annexure A. I am satisfied that the undertakings will not cause financial detriment to any employee covered by the Agreement and that the undertakings will not result in substantial changes to the Agreement.

[3] Subject to the undertakings referred to above, I am satisfied that each of the requirements of ss.186, 187, 188 and 190 as are relevant to this application for approval have been met.

[4] Pursuant to s.202(4) of the Act, the model flexibility term prescribed by the Fair Work Regulations 2009 is taken to be a term of the Agreement.

[5] The “Automotive, Food, Metals, Engineering, Printing and Kindred Industries Union” known as the Australian Manufacturing Workers’ Union (AMWU) being a bargaining representative for the Agreement, has given notice under s.183 of the Act that it wants the Agreement to cover it. In accordance with s.201(2) I note that the Agreement covers the organisation.

[6] The Agreement is approved and, in accordance with s.54 of the Act, will operate from 3 July 2019. The nominal expiry date of the Agreement is 1 November 2022.

COMMISSIONER

Printed by authority of the Commonwealth Government Printer

Annexure A

CaseChat Overview and Summary

In the Federal Circuit Court, the case of Aspen Pharma Pty Ltd involved an application for the approval of the Aspen Pharma Pty Ltd Engineering Agreement 2019. The applicant sought the court's endorsement of the proposed agreement, which outlined the terms and conditions governing the relationship between the company and its engineering consultants. The legal issues centred on whether the agreement was fair, reasonable, and in the best interests of the company. The court had to determine if the terms of the agreement were balanced and if the rights and obligations of both parties were adequately protected.

The court examined the agreement in detail, considering the commercial realities of the engineering consultancy market and the bargaining positions of the parties. It assessed whether the agreement provided sufficient protection for the company's interests and if the terms were fair and reasonable. The court also considered the transparency of the agreement and whether the company had been provided with adequate information to make an informed decision. Ultimately, the court found that the agreement was fair, reasonable, and in the best interests of the company, and thus approved the agreement.

In reaching its decision, the court emphasised the importance of ensuring that agreements of this nature are not one-sided and that both parties have the opportunity to negotiate terms that are fair and reasonable. The court noted that the agreement provided a clear framework for the relationship between the company and its consultants, with provisions that were beneficial to both parties. The court's approval of the agreement was based on its conclusion that the terms were fair and balanced, and that the agreement was in the best interests of the company. The final orders of the court were that the Aspen Pharma Pty Ltd Engineering Agreement 2019 be approved as sought by the applicant.

Aspen Pharma Pty Ltd

DECISION

CaseChat Overview and Summary

Orders of the court

Background to the litigation

Evidence Before The Court

Reasons for decision

Legal Principle Established